BioGaia licenses full range to Austrian firm
Swedish probiotics developer BioGaia has signed a five-year agreement with HSO Pharma in its first deal for a whole range of its products.
News, Analysis & Insights on Nutrition, Supplements, and Health
Swedish probiotics developer BioGaia has signed a five-year agreement with HSO Pharma in its first deal for a whole range of its products.
Most kinds of fibre are related to lower risk of various heart disease risk factors, finds new research on a French population.
Russia could provide supplement and health food makers with attractive opportunities, particularly in the light of a recent warning from the World Bank.